Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Homo sapiens | microtubule-associated protein tau | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Homo sapiens | arachidonate 15-lipoxygenase, type B | Starlite/ChEMBL | No references |
Homo sapiens | X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase | Starlite/ChEMBL | No references |
Caenorhabditis elegans | Protein GLD-1 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) | Protein Rev | Starlite/ChEMBL | No references |
Homo sapiens | plectin | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Leishmania infantum | hypothetical protein, conserved | Protein Rev | 116 aa | 95 aa | 26.3 % |
Leishmania donovani | hypothetical protein, conserved | Protein Rev | 116 aa | 95 aa | 26.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0238 | 0.0528 |
Brugia malayi | VAB-10A protein | 0.0043 | 0.0238 | 0.0528 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0006 | 0.0014 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0 | 0.5 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0055 | 0.0388 | 0.0861 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | MBCTL1 | 0.0055 | 0.0388 | 0.0861 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.1939 | 0.1939 |
Echinococcus multilocularis | baculoviral IAP repeat containing protein | 0.0065 | 0.0519 | 0.0519 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0618 | 0.5 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0 | 0.5 |
Echinococcus multilocularis | protein quaking | 0.0033 | 0.0118 | 0.0118 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0118 | 0.0262 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0135 | 0.1381 | 1 |
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0055 | 0.0388 | 0.0388 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0136 | 0.0136 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Echinococcus multilocularis | polycomb protein SCMH1 | 0.0048 | 0.0306 | 0.0306 |
Schistosoma mansoni | hypothetical protein | 0.0292 | 0.332 | 0.332 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0006 | 0.0014 |
Echinococcus multilocularis | Spectrin alpha actinin | 0.0043 | 0.0238 | 0.0238 |
Echinococcus granulosus | baculoviral IAP repeat containing protein | 0.0065 | 0.0519 | 0.0519 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0618 | 0.0618 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0135 | 0.1381 | 1 |
Brugia malayi | tumor suppressor. | 0.0388 | 0.4507 | 1 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0055 | 0.0388 | 0.0388 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1939 | 0.4303 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0024 | 0.0006 | 0.5 |
Echinococcus multilocularis | RUN | 0.0024 | 0.0006 | 0.0006 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Echinococcus multilocularis | inhibitor of apoptosis protein | 0.0065 | 0.0519 | 0.0519 |
Schistosoma mansoni | hypothetical protein | 0.0065 | 0.0519 | 0.0519 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0142 | 0.1471 | 0.1471 |
Brugia malayi | Temporarily assigned gene name protein 44 | 0.0033 | 0.0118 | 0.0262 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0519 | 0.1152 |
Loa Loa (eye worm) | doublecortin family protein | 0.0024 | 0.0006 | 0.0014 |
Schistosoma mansoni | loxhd1 | 0.0024 | 0.0006 | 0.0006 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0118 | 0.0118 |
Echinococcus granulosus | polycomb protein SCMH1 | 0.0048 | 0.0306 | 0.0306 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0055 | 0.0388 | 0.0388 |
Echinococcus granulosus | Polycystic kidney disease protein | 0.0024 | 0.0006 | 0.0006 |
Schistosoma mansoni | lipoxygenase | 0.01 | 0.0941 | 0.0941 |
Loa Loa (eye worm) | hypothetical protein | 0.0065 | 0.0519 | 0.1152 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.1939 | 0.4303 |
Schistosoma mansoni | rab6-interacting | 0.0024 | 0.0006 | 0.0006 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.0333 | 0.0738 |
Echinococcus multilocularis | SAM and MBT domain containing protein | 0.0048 | 0.0306 | 0.0306 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0306 | 0.0678 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0048 | 0.0306 | 0.0306 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0073 | 0.0618 | 1 |
Loa Loa (eye worm) | mbt repeat family protein | 0.0048 | 0.0306 | 0.0678 |
Echinococcus granulosus | hypothetical protein | 0.0033 | 0.0118 | 0.0118 |
Brugia malayi | hypothetical protein | 0.0024 | 0.0006 | 0.0014 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0065 | 0.0519 | 0.1152 |
Schistosoma mansoni | sex comb on midleg homolog | 0.0048 | 0.0306 | 0.0306 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0833 | 1 | 1 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0 | 0.5 |
Trypanosoma brucei | calpain, putative | 0.0135 | 0.1381 | 1 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0189 | 0.2051 | 0.2051 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0238 | 0.0238 |
Echinococcus granulosus | SAM and MBT domain containing protein | 0.0048 | 0.0306 | 0.0306 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0618 | 1 |
Trypanosoma cruzi | kinetoplast DNA-associated protein, putative | 0.0043 | 0.0238 | 0.1725 |
Echinococcus multilocularis | Polycystic kidney disease protein | 0.0024 | 0.0006 | 0.0006 |
Echinococcus granulosus | RUN | 0.0024 | 0.0006 | 0.0006 |
Brugia malayi | Inhibitor of Apoptosis domain containing protein | 0.0065 | 0.0519 | 0.1152 |
Brugia malayi | Growth-Arrest-Specific Protein 2 Domain containing protein | 0.0043 | 0.0238 | 0.0528 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0142 | 0.1471 | 0.1471 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0136 | 0.0302 |
Onchocerca volvulus | 0.0065 | 0.0519 | 1 | |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.1939 | 0.4303 |
Schistosoma mansoni | inhibitor of apoptosis (iap) domain family member | 0.0065 | 0.0519 | 0.0519 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0238 | 0.0238 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0618 | 0.0618 |
Brugia malayi | hypothetical protein | 0.0033 | 0.0118 | 0.0262 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Onchocerca volvulus | 0.0048 | 0.0306 | 0.5839 | |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0618 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0333 | 0.0738 |
Schistosoma mansoni | rab6-interacting | 0.0024 | 0.0006 | 0.0006 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0135 | 0.1381 | 1 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0006 | 0.0006 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0618 | 0.0618 |
Echinococcus granulosus | Spectrin alpha actinin | 0.0043 | 0.0238 | 0.0238 |
Schistosoma mansoni | scm-relatedprotein containing 4 mbt domains (sfmbt) | 0.0048 | 0.0306 | 0.0306 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.1471 | 0.1471 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0024 | 0.0006 | 0.5 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Onchocerca volvulus | Polycomb protein Sfmbt homolog | 0.0048 | 0.0306 | 0.5839 |
Brugia malayi | mbt repeat family protein | 0.0048 | 0.0306 | 0.0678 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0618 | 0.0618 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0333 | 0.0738 |
Trypanosoma brucei | calpain-like protein, putative | 0.0135 | 0.1381 | 1 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0055 | 0.0388 | 0.0388 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0055 | 0.0388 | 0.0388 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0136 | 0.0302 |
Echinococcus granulosus | protein quaking | 0.0033 | 0.0118 | 0.0118 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0388 | 0.0861 |
Trypanosoma brucei | hypothetical protein | 0.0135 | 0.1381 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0024 | 0.0006 | 0.0006 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.0333 | 0.0738 |
Echinococcus granulosus | lipoxygenase domain containing protein | 0.0024 | 0.0006 | 0.0006 |
Trypanosoma brucei | variant surface glycoprotein (VSG), putative | 0.0135 | 0.1381 | 1 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0006 | 0.0006 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.1939 | 0.1939 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0073 | 0.0618 | 1 |
Loa Loa (eye worm) | spectraplakin | 0.0043 | 0.0238 | 0.0528 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0618 | 0.4473 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0135 | 0.1381 | 1 |
Brugia malayi | mbt repeat family protein | 0.0048 | 0.0306 | 0.0678 |
Loa Loa (eye worm) | hypothetical protein | 0.0024 | 0.0006 | 0.0014 |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.1939 | 0.1939 |
Schistosoma mansoni | inhibitor of apoptosis protein | 0.0065 | 0.0519 | 0.0519 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0833 | 1 | 1 |
Loa Loa (eye worm) | tumor suppressor | 0.0388 | 0.4507 | 1 |
Echinococcus granulosus | inhibitor of apoptosis protein | 0.0065 | 0.0519 | 0.0519 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0189 | 0.2051 | 0.2051 |
Echinococcus multilocularis | lipoxygenase domain containing protein | 0.0024 | 0.0006 | 0.0006 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.0135 | 0.1381 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0135 | 0.1381 | 1 |
Brugia malayi | Doublecortin family protein | 0.0024 | 0.0006 | 0.0014 |
Onchocerca volvulus | Deterin homolog | 0.0065 | 0.0519 | 1 |
Schistosoma mansoni | polycystin 1-related | 0.0024 | 0.0006 | 0.0006 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.6989385 uM | PUBCHEM_BIOASSAY: Counter Screen using XIAP-Bir3 for Chemical Antagonists of Bir1/2 domains of IAP-family anti-apoptotic proteins. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1018, AID1449, AID1514, AID1638, AID1749, AID1750, AID488957, AID488963] | ChEMBL. | No reference |
IC50 (binding) | = 5.308 uM | PUBCHEM_BIOASSAY: Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of GLD-1 protein - TGE RNA interaction. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2280, AID2290, AID2459] | ChEMBL. | No reference |
IC50 (binding) | = 8.072 uM | PUBCHEM_BIOASSAY: uHTS identification of small molecule antagonists of the binding of Siah-1 and a peptide ligand via a fluorescence polarization assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1826, AID2127, AID2141] | ChEMBL. | No reference |
IC50 (binding) | = 10.582 uM | PUBCHEM_BIOASSAY: HTS TR-FRET-based dose response confirmatory assay for Siah-1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1817, AID1826] | ChEMBL. | No reference |
IC50 (binding) | = 11.141 um | PUBCHEM_BIOASSAY: Counterscreen for inhibitors of gld-1: Fluorescence polarization-based biochemical high throughput dose response assay for inhibitors of the HIV Rev protein-RRE RNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2290 (Summary (gld-1 inhibitors)), 2280 (Primary screen (gld-1 inhibitors in singlicate))] | ChEMBL. | No reference |
IC50 (binding) | = 15.282 uM | PUBCHEM_BIOASSAY: HTS fluorescence polarization-based dose response confirmatory screen for the Siah-1 primary assay utilizing an alternative fluorophore, fluorescein-labeled plectin. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1817, AID1826] | ChEMBL. | No reference |
Potency (binding) | 8.9125 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 10 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 23.7781 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 25.929 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1171 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PUBCHEM_BIOASSAY: qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485366, AID485386, AID504448, AID504454, AID504459] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 32.6294 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))] | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 50.1187 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636] | ChEMBL. | No reference |
Potency (functional) | 75.6863 uM | PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 79.4328 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2367, AID593, AID594] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.